Multiple myeloma: lusting for NF-kappaB.

Abstract excerpt

Multiple myeloma (MM) is a late-stage B cell malignancy that has received much attention recently because of its therapeutic susceptibility to proteasome inhibitors. Two papers in this issue of Cancer Cell show that primary MM samples and MM cell lines frequently have mutations in genes encoding regulators and effectors of NF-kappaB signaling, and that these mutations lead to chronic NF-kappaB target gene...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Multiple Myeloma
• Share to Mutation
• Share to NF-kappa B